DalsnaFinance › IPOs › Werewolf Therapeutics › IPO
Werewolf Therapeutics, Inc. completed its initial public offering on NASDAQ on April 30, 2021, pricing at $16.00 a share.
| Ticker | HOWL |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | April 30, 2021 |
| Offering price | $16.00 |
| Shares offered | 7,500,000 |
| Total raised | $120M |
Werewolf Therapeutics, Inc. sold 7,500,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $120 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $120 million total recorded for the deal.
Werewolf Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Werewolf Therapeutics, Inc.. This page is general information, not investment advice.